Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Yolonda L. Colson, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Yolonda Colson and Rong Liu.
Connection Strength

3.058
  1. Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma. Biomaterials. 2016 09; 102:175-86.
    View in: PubMed
    Score: 0.685
  2. Prevention of nodal metastases in breast cancer following the lymphatic migration of paclitaxel-loaded expansile nanoparticles. Biomaterials. 2013 Feb; 34(7):1810-9.
    View in: PubMed
    Score: 0.536
  3. Paclitaxel-loaded expansile nanoparticles delay local recurrence in a heterotopic murine non-small cell lung cancer model. Ann Thorac Surg. 2011 Apr; 91(4):1077-83; discussion 1083-4.
    View in: PubMed
    Score: 0.477
  4. Prevention of local tumor recurrence following surgery using low-dose chemotherapeutic polymer films. Ann Surg Oncol. 2010 Apr; 17(4):1203-13.
    View in: PubMed
    Score: 0.435
  5. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids. J Thorac Cardiovasc Surg. 2015 May; 149(5):1417-24; discussion 1424-25.e1.
    View in: PubMed
    Score: 0.156
  6. Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma. Ann Surg Oncol. 2013 May; 20(5):1684-93.
    View in: PubMed
    Score: 0.133
  7. Paclitaxel-eluting polymer film reduces locoregional recurrence and improves survival in a recurrent sarcoma model: a novel investigational therapy. Ann Surg Oncol. 2012 Jan; 19(1):199-206.
    View in: PubMed
    Score: 0.122
  8. The performance of expansile nanoparticles in a murine model of peritoneal carcinomatosis. Biomaterials. 2011 Jan; 32(3):832-40.
    View in: PubMed
    Score: 0.116
  9. Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies. CA Cancer J Clin. 2018 11; 68(6):488-505.
    View in: PubMed
    Score: 0.050
  10. Reinforcement of polymeric nanoassemblies for ultra-high drug loadings, modulation of stiffness and release kinetics, and sustained therapeutic efficacy. Nanoscale. 2018 May 10; 10(18):8360-8366.
    View in: PubMed
    Score: 0.049
  11. Synthesis of poly(1,2-glycerol carbonate)-paclitaxel conjugates and their utility as a single high-dose replacement for multi-dose treatment regimens in peritoneal cancer. Chem Sci. 2017 Dec 01; 8(12):8443-8450.
    View in: PubMed
    Score: 0.047
  12. Highly Specific and Sensitive Fluorescent Nanoprobes for Image-Guided Resection of Sub-Millimeter Peritoneal Tumors. ACS Nano. 2017 02 28; 11(2):1466-1477.
    View in: PubMed
    Score: 0.045
  13. Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles. Sci Rep. 2016 Jan 07; 6:18720.
    View in: PubMed
    Score: 0.041
  14. Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes. Biomaterials. 2016 Jan; 76:273-81.
    View in: PubMed
    Score: 0.041
  15. Imparting superhydrophobicity to biodegradable poly(lactide-co-glycolide) electrospun meshes. Biomacromolecules. 2014 Jul 14; 15(7):2548-54.
    View in: PubMed
    Score: 0.037
  16. In vitro activity of Paclitaxel-loaded polymeric expansile nanoparticles in breast cancer cells. Biomacromolecules. 2013 Jun 10; 14(6):2074-82.
    View in: PubMed
    Score: 0.034
  17. Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites. J Control Release. 2010 Jun 15; 144(3):280-7.
    View in: PubMed
    Score: 0.028
  18. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. J Am Chem Soc. 2009 Feb 25; 131(7):2469-71.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.